{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260423566221/en/Arrowhead-Pharmaceuticals-Receives-Positive-CHMP-Opinion-Recommending-Approval-of-REDEMPLO%C2%AE-plozasiran-to-Reduce-Triglycerides-in-Adults-with-Familial-Chylomicronemia-Syndrome-FCS-in-Europe", "message": "News view counter 680060 successfully enlarged"}